Physician profile
Robert Karnes
NPI 1699555037
$984.20
in general payments reported to CMS, 2019-2025
14 companies · $470 in 2025
The $470 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $36.89 · 2024: $477 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $366.83 | 2024-2025 | |
| Pfizer INC. | $138.52 | 2024-2025 | |
| Glaxosmithkline, LLC. | $87.11 | 2024-2025 | Shingrix, Arexvy |
| Sumitomo Pharma America, INC. | $67.46 | 2024-2025 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $60.00 | 2023-2025 | Voquezna |
| Lilly USA, LLC | $59.51 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $47.04 | 2025 | Wegovy, Rybelsus, Ozempic |
| Otsuka America Pharmaceutical, INC. | $43.90 | 2023-2024 | Rexulti |
| Astellas Pharma US INC | $27.80 | 2024-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $21.90 | 2025 | Airsupra |
| Silk Road Medical, INC. | $20.13 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Baxter Healthcare | $16.22 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.28 | 2025 | Jardiance |
| Kyowa Kirin, INC. | $13.50 | 2024 | Crysvita |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Karnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.